Supplementary MaterialsSupplementary Information 41467_2018_8115_MOESM1_ESM. the GTPase cycle and impairs binding to effectors. In contrast, SHP2 dephosphorylates KRAS, a process that is required to maintain dynamic canonical Vistide supplier KRAS GTPase cycle. Notably, Src- and SHP2-mediated regulation of KRAS activity extends to oncogenic KRAS and the inhibition of SHP2 disrupts the phosphorylation cycle, shifting the equilibrium… Continue reading Supplementary MaterialsSupplementary Information 41467_2018_8115_MOESM1_ESM. the GTPase cycle and impairs binding to